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Abstract
Background: To facilitate indefinite proliferation, stem cells and most cancer cells require the activity of telomerase,
which counteracts the successive shortening of telomeres caused by incomplete DNA replication at the very end
of each chromosome. Human telomerase activity is often determined by the expression level of telomerase reverse
transcriptase (TERT), the catalytic subunit of the ribonucleoprotein complex. The low expression level of TERT and
the lack of adequate antibodies have made it difficult to study telomerase-related processes in human cells.
Results: To overcome the low CRISPR-Cas9 editing efficiency at the TERT locus, we develop a two-step “pop-in/
pop-out” strategy to enrich cells that underwent homologous recombination (HR). Using this technique, we fuse
an N-terminal FLAG-SNAP-tag to TERT, which allows us to reliably detect TERT in western blots, immunopurify it
for biochemical analysis, and determine its subcellular localization by fluorescence microscopy. TERT co-localizes
detectably with only 5–7 % of the telomeres at a time in S-phase HeLa cells; no nucleolar localization is detected.
Furthermore, we extend this approach to perform single base-pair modifications in the TERT promoter; reverting a
recurrent cancer-associated TERT promoter mutation in a urothelial cancer cell line results in decreased telomerase
activity, indicating the mutation is causal for telomerase reactivation.
Conclusions: We develop a two-step CRISPR-Cas9 genome editing strategy to introduce precise modifications at
the endogenous TERT locus in human cell lines. This method provides a useful tool for studying telomerase biology,
and suggests a general approach to edit loci with low targeting efficiency and to purify and visualize low
abundance proteins.
Keywords: Telomerase, TERT, Cajal body, cancer mutations, CRISPR-Cas9 genome editing, SNAP-tag
Background
All continuously proliferating cells, like stem cells and
cancer cells, require a mechanism to compensate for telo-
mere attrition during continuous division [1]. Most often
this requirement is fulfilled by the telomerase enzyme.
However, somatic cells lack telomerase activity, due to the
transcriptional inactivation of the gene encoding TERT,
the catalytic subunit of the telomerase holoenzyme [2–4].
Reactivation of TERT transcription in somatic cells allows
them to divide indefinitely, which is a crucial step during
tumorigenesis [5]. Therefore, investigating TERT expres-
sion is of great significance to understand how the level of
telomerase activity is regulated under physiological and
pathological conditions.
For several reasons, determining the expression level of
TERT is hampered by the difficulty to detect the endogen-
ous TERT protein. First, TERT is a lowly expressed
protein with only several hundred molecules per cell [6].
Second, commercially available TERT antibodies have
been shown to be either inefficient or non-specific in tar-
geting endogenous TERT [6, 7]. CRISPR-Cas9-mediated
genome editing provides an alternative approach, allowing
tagging of the endogenous TERT protein with a well-
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Furthermore, targeted genome editing also provides an
approach to introduce specific mutations to the en-
dogenous TERT locus and study their effects on TERT
expression. For instance, two point mutations in the pro-
moter region of the human TERT gene (C-124T and C-
146T) have been reported to be highly recurrent in
various cancers types [8, 9] and correlate with higher tel-
omerase levels [10]. Results of luciferase reporter assay
suggest that either mutation increases the transcriptional
activity of the TERT promoter [8]. The association of
these mutations with telomerase activation is well estab-
lished, but the direct causality between these mutations
and the activation of TERT expression in the endogen-
ous context remains uncertain. Modifying the endogen-
ous TERT promoter using genome editing can address
this important question.
Here, we describe methods to modify the endogenous
TERT locus with the CRISPR-Cas9 system, labeling the
endogenous TERT protein with an affinity purification
and localization tag or introducing a single base-pair
modification in the TERT promoter. To overcome the low
efficiency of genome editing at the TERT locus, we de-
signed a two-step protocol similar to the “pop-in/pop-out”
gene replacement method in yeast [11] to facilitate screen-
ing for successfully edited clones. With these methods, we
generated HEK 293 and HeLa cell lines expressing FLAG-
SNAP-tagged TERT protein, allowing efficient immuno-
purification (IP) and subcellular localization of endogen-
ous TERT. Our results demonstrate that telomerase only
localizes to a small number of telomeres at any given time.
We also generated HEK 293T and SCaBER cells with a
modified TERT promoter, suggesting that removing the C-
124T mutation from a urothelial cancer cell line is suffi-
cient to decrease the telomerase level and shorten telo-
meres. These methods not only provide useful tools for
studying telomerase biology, but also offer a general
approach to purify and visualize low abundance proteins,
as well as making single base-pair modifications at gen-
omic sites with low editing efficiency.
Results
Modification of the endogenous TERT protein with an
N-terminal FLAG-SNAP-tag
We found that the efficiency of genome editing in the
TERT 5′ region was very low (see below). We therefore de-
signed a two-step protocol to introduce the sequence cod-
ing for a FLAG-SNAP-tag into the TERT locus (Fig. 1a).
The tag was fused to the N-terminus of TERT because C-
terminal tagging has been shown to impair the ability of
telomerase to elongate telomeres within cells [12].
First, the tag sequence and an enhanced green fluor-
escent protein (eGFP) expression cassette flanked by
LoxP-sites were inserted immediately upstream of the en-
dogenous translational start site of TERT by transfecting a
Cas9-single guide RNA (sgRNA) plasmid [13] and a donor
template (DT) plasmid into cells (Fig. 1a). The fluores-
cence marker expressed from the eGFP cassette was used
to screen for clones that had undergone homologous
recombination (HR). We tested a number of sgRNA se-
quences (Table S1 in Additional file 1) in HEK 293T cells,
and chose to use the sgRNA that directs Cas9 to cut be-
tween the base pairs at the −2 and −1 positions relative to
the translational start site, because it would not target the
DT, thus preventing cutting of an edited allele. We com-
pared circular plasmid versus linearized plasmid as DT
(Table S2 in Additional file 1) to determine whether there
was an effect on targeting efficiency. The percentage of
GFP-positive cells in the Cas9–sgRNA groups was higher
than that in the corresponding control groups lacking
Cas9–sgRNA. However, the targeting rates in both cases
were low (~1 %), demonstrating the utility of the fluores-
cence marker. Because the frequency of non-specific inte-
gration (percentage of GFP-positive cells in the groups
lacking Cas9–sgRNA) was higher using the linear DT, we
chose to use the circular DT for subsequent experiments
to reduce off-target effects.
The validated protocol was then used to edit HEK 293
cells, which carry two copies of the TERT gene. To iso-
late single cell clones, GFP-positive cells obtained by
fluorescence-activated cell sorting (FACS) were seeded
in 96-well plates by limiting dilution. The low efficiency
of eGFP insertion at the TERT locus is readily apparent
from FACS profiles of targeted cells (Fig. 1b). HR was
confirmed by PCR with the primer pairs a–b and c–e
(Fig. 1a, c; Table S3 in Additional file 1); 27 out of 32
clones (84 %) gave rise to PCR products of the expected
size (Fig. 1c). To determine the number of TERT alleles
that had undergone HR, we performed PCR with the
primer pair a–e, demonstrating that all clones had
undergone HR at one of the two alleles (Fig. 1d). We se-
quenced the PCR products of a–b, c–e and a–e from
both alleles. The allele that had undergone HR carried
the expected sequence, while the second allele in all
clones contained small insertions or deletions (indels)
around the Cas9 target site. This suggested that both al-
leles had been cut by Cas9, one being repaired by HR
and the other being repaired by non-homologous end
joining (NHEJ), generating small indels.
Next, we selected a single clone (clone 3 in Fig. 1c) to
carry out the second step of the protocol. This clone
contained a small deletion of 19 bp in the allele repaired
by NHEJ (−1 to +18 relative to the original translation
start site), removing the endogenous start codon and
presumably knocking out TERT protein expression from
this allele. We transiently expressed an eGFP-Cre fusion
protein [14] in this clone to excise the eGFP cassette.
Eight days after transfection, we screened the cell popu-
lation for GFP-negative cells using FACS (Fig. 1e). Single
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cell clones were generated by limiting dilution, and PCR
with primer pair a–d (Fig. 1a; Table S3 in Additional file 1)
was used to confirm the excision of the eGFP expression
cassette (Fig. 1f). All five clones tested were confirmed to
contain the FLAG-SNAP-tag sequence inserted at the 5′
end of the endogenous TERT coding sequence. Gene copy
number analysis verified that all clones contained two cop-
ies of TERT (Additional file 2).
An alternative approach with a puromycin resistance
marker instead of the eGFP fluorescence marker in the
DT plasmid was carried out in HeLa cells (Fig. S1 in
Additional file 1). First, a puromycin-selected cell popula-
tion was used to generate single cell clones. All isolated
clones had undergone HR (Fig. S1a in Additional file 1).
Two days after transient transfection of the eGFP-Cre
plasmid, single cell clones were seeded from the GFP-
positive cell population. All clones generated with this
method had undergone successful excision of the puro-
mycin resistance cassette (Fig. S1b in Additional file 1).
Sequencing of the PCR products verified the FLAG-
SNAP-tagged alleles that had undergone HR, and re-
vealed untagged alleles that contained small indels
around the Cas9 cut site (presumably via NHEJ). Since
HeLa cells carry five or six copies of the TERT gene
[10], the exact number of HR alleles and NHEJ alleles is
unknown.
Analysis of expression and activity of the FLAG-SNAP-TERT
protein
To determine whether the FLAG-SNAP-TERT fusion
protein was expressed in the edited HEK 293 cells, we
analyzed whole cell lysates by western blot. An anti-
FLAG antibody detected a band of the expected size in
the edited clones, but not in the parental HEK 293 cells
(Fig. 2a), confirming the expression of the FLAG-SNAP-
TERT protein. Similarly, FLAG-SNAP-TERT was only
detected in the edited HeLa clones but not in the paren-
tal HeLa cells (Fig. S2a in Additional file 1).
Next, we compared IP of FLAG-SNAP-TERT using a
FLAG antibody with that using a well-established TERT
antibody, which is useful for IP but not for western blots
[15, 16]. As an internal control for the IP we added cata-
lytically inactive ProA-FLAG-TERT (IP control (IP ctrl)).
The ProA-FLAG-tag is smaller than the FLAG-SNAP-
tag, and thus IP ctrl runs at an intermediate size be-
tween endogenous TERT and FLAG-SNAP-TERT on
SDS-PAGE. Anti-FLAG IPs efficiently enriched FLAG-
SNAP-TERT from the edited HEK 293 clones but not
from the parental cells (Fig. 2b; Fig. S2b in Additional
file 1). (Most of the signal in lanes 3–6 of Fig. 2b is due
to the FLAG-SNAP-TERT, because the IP ctrl is present
at low levels as seen in lanes 1–2.) The identity of the
FLAG-SNAP-TERT band was verified by its detection
(See figure on previous page.)
Fig. 1 Inserting the sequence for the FLAG-SNAP-tag in the endogenous TERT locus. a Introducing an N-terminal FLAG-SNAP epitope tag to the
endogenous TERT protein. First, a double-strand break was generated next to the translational start site of TERT with the CRISPR-Cas9 system
(red scissors). Cells that underwent homologous recombination (HR) with the donor template (DT) containing the sequence for the tags and the
SV40-driven enhanced green fluorescent protein (eGFP) expression cassette were screened for GFP signal and confirmed by PCR with primers a, b,
c, and e, the sequences of which are listed in Table S3 in Additional file 1. HA homologous arm, TSS transcription start site. Next, the eGFP
expression cassette was removed from the TERT locus through Cre-mediated recombination, leaving only the sequence for FLAG- and SNAP-tags
and an intervening LoxP site at the 5′ end of the TERT coding sequence. b Fluorescence-activated cell sorting (FACS) screen for GFP-positive HEK
293 cells at the first step. Data shown are from cells transfected with the circular DT only or the circular DT + the Cas9-sgRNA plasmid. Cells with
GFP signal in the green-shaded region were sorted. Inset figure: the green-shaded region enlarged. The DT-only group contained 0.5 % cells in this
region and the Cas9-sgRNA + DT group contained 1.1 % cells in this region. c Sample data of PCR screen for clones that underwent HR. PCR
products amplified by primer pairs a–b (upper panel) and c–e (lower panel), from genomic DNA of the GFP-positive HEK 293 single cell clones and
untreated parental cells, were visualized by gel electrophoresis. Marker: 1 kb DNA ladder (Promega). Among the eight clones shown, six generated
PCR products of the expected sizes in both PCRs (1402 bp for primer pair a–b, 1773 bp for primer pair c–e). Clone 2 only generated the correct
PCR product in the a–b PCR. Clone 9 did not generate any PCR products, as was the case for the parental cells. d Sample data of PCR examination of
the zygosity in the clones, from an experiment in which the sequence of a FLAG-tag and the eGFP expression cassette were inserted into the
endogenous TERT locus in HEK 293T cells. PCR products amplified by primer pair a–e, from genomic DNA of the selected HEK 293T single cell clones
and untreated parental cells, were visualized by gel electrophoresis. PCR with genomic DNA from the parental cells only generated the expected
2384 bp PCR product. Clones carrying the targeted insertion in both TERT alleles should generate only the 3652 bp PCR product. Clones carrying the
targeted insertion in one of the TERT alleles should generate PCR products of both lengths. All eight clones shown were heterozygous for the insertion.
The middle bands (indicated by asterisk) between the 3652 and 2384 bp bands might be the hybrid of one 2384 nucleotide strand and one 3652
nucleotide strand, since it contains the same sequence as the top band corresponding to the edited allele in our sequencing data. The same
experiment was later performed on the HEK 293 clones with the insertion of FLAG-SNAP-tag sequence and the eGFP-expression cassette. The PCR
product from the allele that underwent HR should be 4321 bp, which we failed to obtain, presumably because of the long length. We then regarded
a clone as heterozygous if the 2384 bp product appeared. e FACS screen for GFP-negative cells at the second step. After transfection of the Cre
plasmid or no transfection, cells with low GFP signal (blue-shaded region) were sorted. f Sample data of PCR screen for clones in which the eGFP
expression cassette was excised through Cre recombination. PCR products amplified by primer pair a–d, from genomic DNA of the original
GFP-positive clone without Cre expression (Cre−) and several single cell GFP-negative clones after Cre recombination (Cre+), were visualized by gel
electrophoresis. Marker: 1 kb DNA ladder (Promega). In Cre− cells, the size of the PCR product is 3031 bp. After the eGFP expression cassette is excised
by Cre recombination, the size of the PCR product decreases to 1874 bp
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with both anti-FLAG and anti-TERT antibodies (Fig. 2b).
Both antibodies also readily detected the IP ctrl added to
the parental HEK293 cells, which do not contain FLAG-
SNAP-TERT. Additionally, FLAG-SNAP-TERT was de-
tectable using fluorescence imaging, indicating that the
SNAP-tag is fully functional (Fig. 2b). Similar results
were obtained using the edited HeLa clones (Fig. S2b in
Additional file 1). IP with the TERT antibody also puri-
fied FLAG-SNAP-TERT from the edited clones but not
the parental cells (Fig. 2c; Fig. S2c in Additional file 1).
In addition, the TERT antibody also enriched endogen-
ous TERT from the parental cells. Curiously, wild-type
(WT) TERT bands were also present in the edited
clones, potentially due to usage of the WT TERT start
codon.
To compare the IP efficiency of the FLAG and TERT
antibodies, we carried out IPs without adding the IP ctrl
to the edited clones (IP ctrl was still included with par-
ental cell samples, since it is clearly distinguishable from
endogenous TERT). In all edited cell lines, the anti-
FLAG IP was much more efficient for purifying TERT
(compare each pair of F and T lanes in Fig. 2d). Quanti-
fication of the fluorescence signal indicated that the IP
with the anti-FLAG antibody purified five- to seven-fold
higher amounts of FLAG-SNAP-TERT (Fig. 2d). Thus,
the anti-FLAG IP provides a more efficient purification
of TERT expressed from an endogenous chromosomal
locus than previous methods.
To determine the expression level of FLAG-SNAP-
TERT in the edited clones relative to endogenous TERT,
we compared the amounts of TERT and FLAG-SNAP-
TERT purified using the anti-TERT IP (Fig. 2d; samples
from edited clones did not include IP ctrl). Unexpect-
edly, FLAG-SNAP-TERT in edited clones was present at
approximately 20-fold higher levels than endogenous
TERT in parental cells, even though FLAG-SNAP-
TERT is expressed from its endogenous locus. Reverse
transcription-quantitative PCR (RT-qPCR) analysis in-
dicated the edited clones expressed higher levels of
TERT mRNA than the parental cells (Fig. S2d in Additional
file 1), suggesting that the sequence of the FLAG-SNAP-tag
improved TERT transcription and/or TERT mRNA
stability.
Finally, we tested the enzymatic activity of FLAG-
SNAP-TERT to determine whether the tag interfered
with the catalytic function of TERT. Telomerase purified
using the FLAG and TERT antibodies was used in direct
telomerase extension assays, measuring incorporation of
radioactive dGTP into a telomeric oligonucleotide pri-
mer. As expected, anti-TERT IP resulted in telomerase
activity from all cells, while anti-FLAG IP showed tel-
omerase activity only in the edited clones (Fig. 2e; Fig.
S2e in Additional file 1). In the edited clones, the FLAG
antibody precipitated four- to eight-fold more telomer-
ase activity than the TERT antibody, consistent with the
increased efficiency of TERT IP (Fig. 2d, e). Further-
more, in the edited clones 3 and 4, IP with the TERT
antibody yielded two- to five-fold more telomerase activ-
ity than in the parental cells, consistent with TERT being
overexpressed. Clones 1 and 5 did not show elevated tel-
omerase activity; the reason for this clonal variation is
unknown. Accordingly, we observed telomere lengthen-
ing in clones 3 and 4 but not clones 1 and 5 (Fig. 2f ).
Activity in edited HeLa clones was comparable to the in-
creased activity in HEK 293 clones 3 and 4 (Fig. 2g). The
observation that the fold increase in the telomerase
activity (less than five-fold) is much lower than the fold-
increase in the protein level (20-fold) is presumably
because the amount of telomerase RNA (TR), the other
key component of the telomerase catalytic core, limits
telomerase assembly. This was anticipated from the en-
dogenous molecule numbers of TERT and TR previously
(See figure on previous page.)
Fig. 2 Expression, purification and activity of the FLAG-SNAP-TERT protein. a Western blot of lysates of parental HEK 293 cells and edited clones
expressing FLAG-SNAP-TERT using a FLAG antibody. Bands at the expected size of FLAG-SNAP-TERT (arrow) indicate that the fusion protein is
expressed in the edited clones. b FLAG-SNAP-TERT immunopurified with a FLAG antibody from parental HEK 293 cells and various edited clones
was revealed by western blot using antibodies against the FLAG-tag and TERT. Fluorescence was detected using SNAP Surface® 594 dye covalently
bound to the SNAP-tag. All samples were supplemented with IP control (IP ctrl). c FLAG-SNAP-TERT immunopurified with a TERT-antibody from
parental HEK 293 cells and various edited clones was revealed by western blot using antibodies against the FLAG-tag and TERT. A band with
the size of endogenous TERT was also observed on the western blot of the modified clones, which should not arise from the NHEJ allele as
the start codon was removed by the indel. One possibility is that the original start codon for the endogenous TERT on the FLAG-SNAP allele
was still used to some extent instead of the start codon before the FLAG-tag sequence. Fluorescence detection and IP ctrl is as in panel (b). d Western
blots and fluorescence imaging, comparing the IP efficiency of FLAG-SNAP-TERT using the anti-FLAG (F) or anti-TERT (T) antibody. e Direct telomerase
activity assay of telomerase purified from parental HEK 293 cells and various edited HEK 293 clones with the anti-FLAG or anti-TERT antibody. Note lack
of telomerase activity in lane 1 because no FLAG-labeled TERT is expressed in the parental cells. LC1 and LC2 are two oligonucleotide loading controls.
f Telomeric restriction fragment length analysis by Southern blot of parental HEK 293 cells and several edited clones expressing FLAG-SNAP-TERT. Cells
were harvested at the indicated time points. Average telomere lengths are plotted in the lower panel. Clones 3 and 4, which have higher levels of
telomerase activity as shown in panel (e), have elongated telomeres. g Direct telomerase activity assay of telomerase purified from parental HEK 293
cells and various edited HEK 293 and HeLa clones using the anti-TERT antibody. Cells were transfected with a telomerase RNA expression plasmid (TR OE)
to assure that FLAG-SNAP-TERT was the limiting component for telomerase assembly. IP ctrl was included in one sample after cell lysis to confirm that it
did not affect telomerase activity. LC1 and LC2 are two oligonucleotide loading controls. Quantitative analysis of the data is plotted in the lower panel
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measured [6], and was also indicated by transient over-
expression of TR in the edited clones, which further
increased their telomerase activity (Fig. 2g).
In summary, these results demonstrate that the FLAG-
SNAP-tag allows a higher IP efficiency and retains the
enzymatic activity of TERT.
Subcellular localization of FLAG-SNAP-TERT
The localization of TERT in human cells has been inferred
from many studies with overexpressed tagged protein
[17–20]. Although cytolocalization of endogenous TERT
has been reported [21, 22], such studies have been frus-
trated by the low abundance of TERT and lack of a good
antibody. Here, we use FLAG-SNAP-TERT expressed
from the endogenous locus as a surrogate for endogenous
TERT, realizing that the overexpression due to insertion
of the tag, although much more modest than that pro-
duced by standard transient transfection, could neverthe-
less influence the results. CRISPR-edited HeLa clones
were used for these experiments because HeLa cells attach
to the glass surface better than HEK 293 cells. We labeled
the FLAG-SNAP-TERT using a cell-permeable substrate
for the SNAP-tag (BG-647-SiR) [23]. Cells were fixed and
stained for TRF2 and coilin to visualize telomeres and
Cajal bodies, respectively.
Cells containing FLAG-SNAP-TERT displayed bright foci
at telomeres and Cajal bodies, the expected localization
sites of TERT. No nucleolar staining of TERT was ob-
served, in contrast to previous immunofluorescence (IF) ex-
periments using an anti-TERT antibody [17, 21]. The
parental HeLa cells showed only background staining
(Fig. 3; for full field-of-view images see Data files 3–6 in
Additional file 3). Z-stacks of the cells were also analyzed to
assure the co-localization (Fig. S3a in Additional file 1).
Since telomerase is recruited to telomeres during S phase
of the cell cycle [21, 24], we compared cells synchronized in
S phase and G1 phase (Fig. 4a–c; for full field-of-view im-
ages see Data files 3, 7 and 8 in Additional file 3). We found
each S-phase nucleus contained approximately 40 TRF2
foci (Fig. S3b in Additional file 1), instead of the 150–300
telomeres present in a HeLa cell pre- and post-replication,
respectively. Thus, the foci presumably contain clusters of
around four to eight telomeres on average. Most S-phase
cells contained a small fraction of telomere clusters that co-
localized with TERT (~5 %). These results suggest that only
a small number of telomeres are being elongated at any
given time point, even in S phase.
Fig. 3 Subcellular localization of FLAG-SNAP-TERT. IF analysis of fixed HeLa cells expressing FLAG-SNAP-TERT. The SNAP-tag was labeled with
SNAP-Cell® 647-SiR dye (scale bar = 5 μm). Telomeres and Cajal bodies were stained with antibodies against TRF2 and coilin, respectively. Edited
cells but not parental cells showed FLAG-SNAP-TERT foci that co-localized with telomeres and Cajal bodies. Two independent clones expressing
FLAG-SNAP-TERT were used to generate the images shown
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To further analyze telomere recruitment of telomerase
during S phase, we synchronized edited HeLa cells at
the G1/S border using a double thymidine block and
visualized TERT localization to telomeres as cells pro-
gressed through S phase (Fig. 4d). TERT localization in-
creased throughout the first 4–6 hours of S phase, at
which point it reached its maximal frequency of a mean
of around three co-localizations per cell, which corre-
sponded to ~7 % of TRF2 foci (Fig. 4e; Fig. S4 in
Additional file 1; for full field-of-view images see Data
files 3, 9-14 in Additional file 3). After completion of
DNA synthesis (9–10 hours post-release), TERT
localization dropped to its minimum (mean of around
one co-localization per cell), indicating that telomerase
dissociates from telomeres in G2 phase of the cell cycle.
These observations are consistent with previous results
obtained using fluorescence in situ hybridization (FISH)
for TR, the RNA component of telomerase [21].
Thus, the SNAP-tag enables subcellular localization of
the lowly expressed TERT, and its localization at biologic-
ally functional sites demonstrates that TERT function is
not impaired by the N-terminal FLAG-SNAP-tag or by
the modest overexpression. The number of Cajal bodies
per cell (typically one to four; Fig. S3c in Additional file 1)
was indistinguishable from that observed in the parental
HeLa cells, in contrast to cells with highly overexpressed
telomerase where unnatural neo-Cajal bodies associate
with every telomere [19, 20]. It is worth noting antibodies
against the FLAG-epitope did not detect FLAG-SNAP-
TERT at telomeres, due to background foci (Data file 3, 15
in Additional file 3), indicating that the SNAP labeling is
more specific than conventional IF labeling.
Single base-pair modification in the endogenous TERT
promoter
Recently, two highly recurrent point mutations were iden-
tified in the TERT promoter in multiple cancers and shown
to be associated with telomerase activation during tumori-
genesis. To explore the effects of these mutations on TERT
expression levels in the endogenous context, we extended
our two-step “pop-in/pop-out” strategy to modify single
base pairs in the TERT promoter (Fig. 5a). A single base-
pair substitution was first introduced into the TERT
promoter alongside an eGFP expression cassette, which
was then removed by a second round of CRISPR-mediated
editing, resulting in a TERT promoter with only a single
base-pair alteration.
The protocol was first tested using HEK 293T cells,
which contain WT TERT promoter sequences. Ten
sgRNA sequences were tested, and a sequence directing
Cas9 to cut between the −148 and −147 positions rela-
tive to the endogenous translational start site was
chosen based on its targeting efficiency and position of
cleavage (Table S1 and Fig. S5 in Additional file 1). The
DT for the first step contained the C-146T mutation
and an eGFP cassette inserted between base pairs −140
and −139, which disrupted the sgRNA recognition site.
On days 6, 14 and 20 post-transfection, three rounds of
FACS were carried out to enrich for the GFP-positive
cells, from which single cell clones were generated.
PCR with the primer pair a’–b or c’–e’ (Fig. 5a; Table
S3 in Additional file 1) was used to identify clones that
had undergone HR. PCR with the primer pair a’–e’
suggested that both TERT alleles had undergone HR
(homozygous) in two clones, while in another three
clones only one TERT allele had undergone HR (hetero-
zygous) (Fig. S6a in Additional file 1). Sequencing of
the PCR products revealed that two out of the three
heterozygous clones had a small insertion of two cyti-
dines between −148 and −147 in the allele that had not
undergone HR. Quantification of the TERT mRNA
levels demonstrated that TERT expression was reduced
to 10 % and 60 % of WT level in the homozygous and
heterozygous clones, respectively, indicating that the in-
sertion of the eGFP expression cassette in the TERT pro-
moter disrupted transcription (Fig. S6b in Additional file 1).
The decrease in the TERT mRNA levels correlates
with the decrease in the levels of TERT protein and
telomerase activity, as well as telomere shortening
(Fig. S6c, d in Additional file 1).
We then used a heterozygous clone (clone 5) to carry
out the second step of the protocol, removing the eGFP
(See figure on previous page.)
Fig. 4 TERT localizes to telomeres in S but not G1 phase of the cell cycle. a IF analysis of fixed HeLa cells expressing FLAG-SNAP-TERT, synchronized in
G1 and S phase of the cell cycle (scale bar = 5 μm). Cells expressing FLAG-SNAP-TERT displayed telomere-localized TERT foci in S but not G1 phase of
the cell cycle, while parental cells never showed telomere-localized TERT foci. b FACS analysis of the DNA content of cells synchronized in S phase
showed a peak between the 2 N and 4 N peaks of asynchronous cells, confirming that they were in S phase. The G1 cell population contained 2 N
and 4 N peaks but was depleted for cells with intermediate DNA content. 4 N cells, which failed to release from their mitotic arrest, were easily
distinguished from G1 cells by their morphology. c Quantification of the number of TERT foci which co-localized with TRF2 signals in edited HeLa cells
synchronized at different stages of the cell cycle. Data were generated from two independent experiments, each analyzing 50 cells per condition
(mean ± standard deviation). d FACS analysis of the DNA content of edited HeLa cells released from a double thymidine block as they transition
through S phase. Prior to release, the cell population contained mostly cells with 2 N DNA content, which progressively increased as the cells
underwent DNA replication. Nine to ten hours after release, DNA replication was complete, as indicated by the majority of cells having 4 N DNA
content. e Quantification of the number of TERT foci co-localized with TRF2 signals at different time points during S phase (50 cells per time point,
mean ± standard error of the mean; for corresponding images see Fig. S4 in Additional file 1). A.U. arbitrary units, Propidium Iodide (PI)
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cassette. Two Cas9-sgRNA plasmids targeting the edges
of the eGFP cassette (Table S1 in Additional file 1) were
co-transfected with the DT plasmid, which contained the
sequence of TERT locus from −589 to +353, and included
the C-146T point mutation. Eight days post-transfection,
the cell population was analyzed by FACS. The Cas9−
group (transfected with only the DT) contained ~11.7 %
GFP-negative cells, which could be due to epigenetic si-
lencing of the eGFP expression cassette. The Cas9+ group
contained a higher percentage of GFP-negative cells
(~16.5 %). The GFP-negative cells in the Cas9+ group
were used to generate single cell clones. Eighty clones
were screened by PCR with the primer pair a’–e’ and se-
quencing, among which two were identified that had
undergone HR to remove the eGFP expression cassette
and had incorporated the C-146T mutation (Fig. S6e in
Additional file 1). Copy number variation analysis verified
that both clones have two copies of TERT. The remaining
clones either contained small indels or had lost one copy
of the TERT gene (Additional file 2). TERT mRNA levels
in the two C-146T clones measured by RT-qPCR were not
higher than that in the parental HEK 293T cells (Fig. S6f
in Additional file 1). However, since TERT expression is
activated through an alternative mechanism in HEK 293T
cells, it is perhaps not surprising that the introduction of
the TERT promoter mutation did not lead to a further in-
crease of TERT expression.
To determine the effects of the TERT promoter muta-
tions in a context where they would be functional, we used
the established protocol to modify the TERT promoter in
SCaBER, a urothelial cancer cell line which contains two
TERT alleles, one of which carries the C-124T mutation
[10]. Based on the hypothesis that the C-124T allele is
more active in transcription than the WT allele, we tar-
geted the C-124T allele to revert the mutation, since it
has been suggested that the CRISPR-Cas9 system has
increased accessibility in transcriptionally active regions
[25]. A DT with the eGFP cassette inserted in the WT
promoter sequence was used for the first step of edit-
ing. Out of 18 GFP-positive clones generated, 16 (89 %)
contained the eGFP cassette inserted into the TERT
locus. Based on sequencing results, we identified a
clone in which the C-124T allele had undergone HR
while the WT allele had neither undergone HR nor con-
tained indels. This clone was subjected to the second
round of genome editing to remove the eGFP cassette.
Out of 200 clones analyzed by PCR and sequencing, three
were found to contain only the WT TERT promoter
sequence (Fig. 5b). Copy number variation analysis dem-
onstrated that all three clones had two copies of TERT
(Additional file 2), ruling out the possibility that the
mutant TERT allele was lost during editing.
To determine the effect of reverting the promoter muta-
tion on TERT transcription, we analyzed TERT mRNA
levels by RT-qPCR. The three clones exhibited reduced
mRNA levels relative to the parental SCaBER cells
(Fig. 5c). To assess whether the reduced TERT transcrip-
tion had functional consequences, we tested the telomer-
ase activity in these modified clones with direct
telomerase extension assays following TERT IP. The cellu-
lar telomerase activity levels were decreased by 40–50 %
in the modified clones compared with the parental cells
(Fig. 5d). Consistent with these results, telomere shortening
was observed in the edited clones (Fig. 5e). Furthermore, all
clones grew at a slower rate compared with the parental
cells (Fig. 5f). These results suggest that the C-124T muta-
tion in the SCaBER cell line is necessary for full activation
of TERT expression. Reverting the mutation in the TERT
promoter decreases telomerase levels and telomere length,
and thereby limits the growth of these cancer cells.
Discussion
We developed several two-step “pop-in/pop-out” strat-
egies for precise genome editing at the endogenous
(See figure on previous page.)
Fig. 5 Single base-pair modification at the endogenous TERT promoter. a Outline of the protocol to modify a single base pair at the endogenous
TERT promoter. First, a double-strand break was generated at the endogenous TERT promoter next to the targeted base pair with the CRISPR-Cas9
system (red scissors). Cells that underwent HR with the DT containing the SV40-driven eGFP expression cassette and the single base-pair modification
were screened by GFP signal and confirmed by PCR with primers a’, b, c’, and e’, the sequences of which are listed in Table S3 in Additional file 1. HA
homologous arm, TSS transcription start site. Next, the eGFP expression cassette was excised by two double-strand breaks generated by the
CRISPR-Cas9 system. Cells that underwent HR with the DT containing the modified TERT promoter sequence were screened based on the loss
of the fluorescent signal and sequencing the PCR products generated with primers a’ and e’. b Sample sequencing data demonstrating the
reversion of the C-124T mutation from the TERT promoter in SCaBER cells. Peak color: red, T; green, A; blue, C; black, G. c TERT mRNA levels in
the modified SCaBER clones are plotted relative to that in the parental cells (1.0, dashed line), as was measured by RT-qPCR with GAPDH mRNA
as an internal control. The black line in each group of data points indicates the median value. As a group, the three clones had significantly
reduced mRNA levels relative to the parental cells (p = 0.04 by Wilcoxon rank-sum test). d Telomerase activity in the modified SCaBER clones
was lower than that in the parental cells, as measured by the IP-direct extension assay (LC loading control). Signal of the extension products
on the gel was normalized to the LC signal and GAPDH protein levels in the IP input, which were quantified by western blot. The quantitative
result is shown in the bar graph (mean ± standard deviation, n = 3 biological replicates, *p < 0.05 by Student’s t-test). e Telomeric restriction
fragment length analysis by Southern blot in the parental cells and modified clones. Cells were harvested at the indicated time points. The
average telomere length in each sample is plotted in the lower panel. *λ DNA-HindIII digest markers. f Growth curves for the parental cells
and modified clones
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TERT locus, which allowed us to label the TERT protein
with an N-terminal epitope tag and facilitated single
base-pair modifications in the TERT promoter. Using
cells edited with this strategy, we achieved detection of
TERT protein and IP of telomerase with unprecedented
efficiency, and we demonstrated that telomerase was
only detectable at 5–7 % of telomeres at any time in S
phase. We also corrected a cancer-associated TERT pro-
moter mutation in a urothelial cancer cell line and showed
that the telomerase level and growth rate of these cancer
cells were decreased.
Strategies for precise genome editing at endogenous loci
with low targeting efficiency
CRISPR-Cas9-mediated genome editing provides an easy
and rapid way to introduce targeted modifications in the
human genome. However, targeting efficiencies vary
greatly among different loci [26]. When we attempted to
utilize CRISPR-Cas9-mediated genome editing to study
telomerase biology, we found TERT to be one of the loci
with a low targeting efficiency. Because TERT is not a very
actively transcribed gene, its chromatin environment
might prevent the access of the Cas9–sgRNA complex.
Another potential explanation is that the high GC content
around the TERT 5′ region might block target recognition
by the Cas9–sgRNA complex — for example, because the
DNA was difficult to melt or because it formed higher-
order structures like G-quadruplexes. To overcome this
hurdle, we employed a “pop-in/pop-out” approach similar
to that used in yeast genome editing, including a marker
to enrich for clones that had undergone HR. Screening for
fluorescent cells (or selecting for drug-resistant cells)
greatly enriched the desired clones in the first step; over
80 % of the GFP-positive clones had undergone HR. It
should be pointed out that careful analysis of the zygosity,
sequence and copy number of the targeted gene is crucial,
as we found that a large percentage of the clones that had
one TERT allele modified by HR contained small indels in
the other allele, which was presumably also cut by Cas9
but then repaired through NHEJ. We also observed that
some clones lost a copy of TERT after editing, most likely
due to the telomere-proximal location of TERT causing
partial chromosome loss after the induction of a double-
strand break.
Parallel experiments using a circular plasmid or a linear
plasmid as the DT demonstrated that their efficiency of
integration through HR is similar (circular, 1.0 %; linear,
1.2 %; Table S2 in Additional file 1). However, the linear
plasmid is more frequently integrated into off-target sites
in the genome. We therefore chose the circular DT be-
cause the ratio of specific to non-specific DT integration
in the GFP-positive clones was higher.
During the “pop-out” step, the marker expression cas-
sette was removed through Cre-mediated recombination,
in the case of introducing the FLAG-SNAP-tag. A LoxP
site remained between the FLAG- and the SNAP-coding
sequences, but it did not interfere with the function of
either tag. To generate single base-pair modifications, a
second round of CRISPR-Cas9-mediated editing was
necessary. Loss of the fluorescence marker was used to
enrich for clones that had eliminated the eGFP expression
cassette, and 1.5 % of the selected clones contained the de-
sired sequence alteration. The frequency and specificity of
our approach might be further improved with previously
described methods such as using the D10A Cas9 nickase,
genetically or chemically inhibiting the NHEJ pathway, or
cell cycle synchronization [27–30].
An unanticipated observation was that the insertion of
the FLAG-SNAP-tag sequence increased the expression of
the TERT gene. As mentioned above, TERT has a very
specific sequence context around its 5′ region, which is
presumably responsible for its low transcriptional activity.
The insertion of the FLAG-LoxP-SNAP sequence may
somehow interrupt this state and improve the transcrip-
tion level. In general, C-terminal tagging might be less
likely to alter the transcription level. However, C-terminal
tagging of TERT impairs its function within cells [12] and
therefore was not an option for our studies. In addition,
the SNAP-tag could function as a solubility tag, stabilizing
the TERT protein. In the future, different tags could be
tested, in order to identify ones that have little effect on
TERT expression. Importantly, the total amount of assem-
bled telomerase holoenzyme was only increased less than
five-fold based on our telomerase activity measurements.
Therefore, the modification of TERT with the FLAG-
SNAP-tag should only have minimal effects in telomerase
biology.
Telomerase distributed unevenly among telomeres at S
phase
Using the FLAG-SNAP-TERT clones, we analyzed the
subcellular localization of the endogenously produced
TERT protein. As expected, TERT localized to Cajal
bodies and telomeres. Previous studies using anti-TERT
antibodies also detected non-telomere associated foci
[21] and signals associated with nucleoli [17, 21, 22],
which were not seen in our experiments and may reflect
a lack of specificity of IF detection of TERT. In contrast
to overexpressed telomerase, which localizes to all the
telomeres detected in S phase [19], the endogenously
produced TERT was only detectable at 5–7 % of TRF2
foci in S phase, which could represent clusters of mul-
tiple telomeres recruiting telomerase. This observation
indicates that the endogenous telomerase only elongates
a limited number of telomeres at any given time point.
Previous studies have suggested that all telomeres in
human cancer cells are elongated in each cell cycle [31],
which requires telomerase recruitment to each telomere.
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In budding yeast, telomerase does not extend all telo-
meres in any given cell cycle, but rather only the short-
est telomeres [32]; consistent with this finding, only a
subset of telomeres co-localize with yeast TR during S
phase [33]. Our data in human cells are consistent with
recruitment of telomerase to a subset of telomeres at
any given time point in S phase, but we cannot rule out
that a small number or a single telomerase holoenzyme
localizes to each telomere, because our method is not
sensitive enough to detect single molecules.
If telomerase is recruited to only a small number of
telomeres at any given time point, sequential telomere
elongation would have to occur to add telomeric repeats
to many or all telomeres in a single cell cycle. Our data
are consistent with the model in which telomeres
sequentially recruit telomerase, potentially controlled by
the replication timing of individual telomeres, which
differs dramatically among chromosomes [34]. In agree-
ment with this notion, TERT localization to telomeres is
maximal in the middle of S phase. Importantly, recruit-
ment of telomerase to telomeres does not necessarily
have to lead to telomere elongation. Telomerase might
be recruited to every telomere in a single S phase but
only elongate a subset of them. Several studies have
suggested that the shortest telomeres are preferentially
elongated in human cells [35, 36], but in these cases
telomerase was overexpressed, which has been shown to
deregulate telomerase recruitment to telomeres [19].
Alternatively, our data are also consistent with only a
subset of telomeres being elongated in a single cell cycle.
To distinguish these models, time-lapse microscopy of
telomerase recruitment to telomeres throughout S phase
will be necessary.
Reverting a cancer-associated TERT promoter mutation
decreased telomerase levels and limited the growth rate
of cancer cells
Recent studies of various human cancer genomes have
identified two highly recurrent TERT promoter mutations
(C-124T and C-146T) [8, 9, 37–39], which generate new
binding sites for the ETS transcription factor GABP [40].
Luciferase reporter gene assays comparing WT/mutant
TERT promoter sequences suggested that promoters with
either of the two mutations drive higher levels of gene ex-
pression (approximately two-fold increase compared with
WT) [8]. Quantitative analysis of endogenous TERT ex-
pression levels, cellular telomerase activity and telomere
lengths in cancer cell lines with or without these muta-
tions has demonstrated that these mutations are associ-
ated with higher levels of telomerase and longer telomere
lengths [10]. To test the causality between the mutations
and endogenous telomerase levels, we edited the endogen-
ous TERT promoter, allowing us to make comparisons
among presumptively isogenic cell lines. Reverting the C-
124T mutation in a urothelial cancer cell line, which ori-
ginally carried one WT allele and one C-124T mutant al-
lele, resulted in decreased telomerase levels, telomere
shortening and reduced proliferation rate of these cells.
One caveat of our genome editing protocol is that the
expression level of TERT affects cell growth. Both steps
(insertion of the eGFP cassette in the promoter and
introducing C at position −124 instead of T) would de-
crease the TERT expression level and render the desired
clones at a selective disadvantage. This would greatly
decrease the success rate of getting a desired clone; and
it also led to the concern that the three SCaBER clones
we obtained might have collected other mutations that
counteract the effects of loss of the C-124T mutation
and increase telomerase levels. This raises a general
question about how to target genes that affect cell
growth. One potential solution would be to supply a
functional copy of the gene during the editing process
and remove it afterwards. In addition, any potential off-
target effects of the genome editing could also affect the
phenotypes of clones. To help control for the off-target
effects, one could introduce both WT and mutant pro-
moter sequences to replace the eGFP expression cassette
integrated in the first step of genome editing. Due to these
potential concerns, we realize the phenotypes we observed
might reflect more than just the loss of the TERT pro-
moter mutation.
Interestingly, introducing the C-146T mutation in HEK
293Tcells, which originally carried two WTalleles, was in-
sufficient to increase the level of telomerase. In our HEK
293T cell genome editing, a small insertion of two cyti-
dines was incorporated in the allele that underwent NHEJ;
it is possible that this insertion reduced the transcription
of TERT, which neutralized the activation effect of the C-
146T mutation on the allele that underwent HR. However,
the fact that clones with one CC-insertion allele and one
eGFP cassette-insertion allele have ~40 % of the telomer-
ase level compared with parental cells suggested the CC-
insertion does not greatly affect TERT expression (Fig. S6
in Additional file 1). Another possibility is that the C-
124T mutation and the C-146T mutation function
differently. But a more likely explanation would be that,
because HEK 293T cells have already activated TERT
expression through an alternative mechanism, the rate-
limiting step that can be facilitated by the promoter
mutation has already been surmounted by other means.
Whatever the mechanism, these results highlight the
importance of genomic background in the functional
investigation of disease-related mutations.
Conclusions
The 5′ region of the human TERT gene has a very low
efficiency for CRISPR-Cas9 genome editing. This limita-
tion was overcome by devising two-step “pop-in/pop-out”
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editing strategies, either screening for the insertion of an
eGFP gene or selecting for insertion of a puromycin-
resistance gene. In one set of experiments, insertion of a
FLAG-SNAP-tag at the N-terminus of TERT allowed reli-
able detection of the protein, efficient IP of active telomer-
ase ribonucleoprotein complexes, and cytolocalization.
Typically, only 5–7 % of clustered telomeres showed de-
tectable telomerase co-localization at any one time in S
phase. One possible explanation is that telomerase is re-
cruited to telomeres sequentially rather than simultan-
eously. Another set of experiments introduced single
base-pair changes in the TERT gene promoter at sites of
recurrent cancer-specific mutations, which had previously
been found to be associated with increased telomerase
activity. Reverting the heterozygous C-124T mutation in a
urothelial cancer cell line suggested the causality of the
mutation for telomerase activity, telomere length mainten-
ance and cell growth rate. More generally, our studies
show how introducing protein tags at endogenous loci
with genome editing can overcome multiple constraints
with purifying and visualizing low-abundance proteins.
Materials and methods
Cell culture
HEK 293 cells (ATCC), HEK 293T cells (ATCC) and
HeLa-EM2-11ht cells (Tet Systems Holdings GmbH
and Co. KG) were grown in high glucose Dulbecco’s
modified Eagle medium (DMEM) supplemented with
10 % fetal bovine serum (FBS), 2 mM GlutaMAX™-I
(Life Technologies), 100 units/ml penicillin and 100 μg/ml
streptomycin at 37 °C with 5 % CO2. SCaBER cells, a gift
from D. Theodorescu (University of Colorado Cancer
Center, Denver), were grown in minimum essential
medium (MEM) supplemented with 10 % FBS, 2 mM
GlutaMAXTM-I, 0.1 mM minimal non-essential amino
acids (Life Technologies), 1 mM sodium pyruvate, 100
units/ml penicillin and 100 μg/ml streptomycin at 37 °C
with 5 % CO2.
Plasmid construction and transfection
sgRNA sequences (Table S1 in Additional file 1) were
cloned individually into the pX330 plasmid vector as
described in [13]. DT sequences with the eGFP/puro-
resistance expression cassette for both methods were
synthesized by GENEWIZ and cloned into the pUC57-
Kan plasmid. The DT with the endogenous TERT se-
quence from −589 to +353 was PCR amplified from the
HEK 293T genomic DNA and cloned into the pUC57-
Kan plasmid. The QuickChange II XL Site-Directed
Mutagenesis Kit (Agilent Technologies, 200522) was used
to modify the DT plasmids with corresponding mutations.
The sequences of all the DT plasmids are provided as
Data files 16-19 in Additional file 4. pBS598 EF1alpha-
EGFPcre plasmid [14] was purchased from Addgene.
The Nucleofector™ 2b Device (Lonza) was used to
introduce pX330 Cas9-sgRNA plasmids and pUC67-Kan
DT plasmids into cells. For HEK 293 and HEK 293T
cells, Amaxa™ Cell Line Nucleofector™ Kit V was used as
transfection reagent according to the manufacturer’s in-
structions. For each transfection, one million cells were
transfected with 2.5 μg pX330 Cas9-sgRNA plasmids
and 2.5 μg pUC67-Kan DT plasmids. For SCaBER cells,
Cell Line Optimization Nucleofector™ Kit for Nucleo-
fector™ Device was first used to optimize the transfec-
tion conditions. Based on the results, Amaxa™ Cell Line
NucleofectorTM Kit V and Program L-029 were chosen.
For each transfection, 0.5 million cells were transfected
with 2.5 μg pX330 Cas9-sgRNA plasmids and 2.5 μg
pUC67-Kan DT plasmids. For HeLa cells, one million
cells were transfected with 1.0 μg pX330 Cas9-sgRNA
plasmids and 1.0 μg pUC67-Kan DT plasmid using Li-
pofectamine® 2000 Reagent (Invitrogen) according to
the manufacturer’s instructions. The pBS598 EF1alpha-
EGFPcre plasmid was transfected with Lipofectamine®
2000 into both HEK 293 and HeLa cells.
FACS
Trypsinized cells were spun down at 200 g for 5 min
and re-suspended in phosphate-buffered saline (PBS)
with 3 % bovine serum albumin (BSA). The cells were
sorted based on the GFP signal on a MoFlo™ XDP cell
sorter (Beckman).
Genomic DNA extraction, genotyping and copy number
variation analysis
Genomic DNA samples were prepared with QuickExtract™
DNA Extraction Solution (Epicentre) or GenElute™ Mam-
malian Genomic DNA Miniprep Kit (Sigma-Aldrich)
according to the manufacturers’ instructions. Sequences of
the TERT locus were PCR amplified for Sanger sequencing
with the corresponding primers (Table S3 in Additional
file 1) as described in [10]. Copy number variation analysis
was performed on a StepOne™ Real-Time PCR instrument
(Life Technologies) using FAM-labeled TaqMan™ Assays
as described in [10].
RNA extraction and RT-qPCR
Total RNA samples were extracted with TRIzol® Reagent
(Ambion) according to the manufacturer’s instructions.
For SCaBER, cells were first treated with 0.5 μg/μl pro-
teinase K in TE buffer (10 mM Tris–HCl pH 8.0, 1 mM
EDTA) at 65 °C for 20 min and then homogenized by
TRIzol®. The extracted total RNA samples were treated
with RQ1 RNase-free DNase (Promega) to eliminate
genomic DNA contamination. cDNA was then prepared
using the High Capacity cDNA Reverse Transcription
kit (Applied Biosystems). RT-qPCR was performed with
iQ™ SYBR® Green Supermix (Bio-Rad) on the
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LightCycler® 480 Real-Time PCR System (Roche) with
primers described in [6].
Telomerase IP and telomerase activity assay
FLAG IP was performed with Anti-FLAG® M2 Affinity
Gel (Sigma-Aldrich, A2220) on HEK 293/HeLa cell lysates
prepared with CHAPS lysis buffer (10 mM Tris–HCl
pH 7.5, 1 mM MgCl2, 1 mM EGTA, 0.5 % CHAPS, 10 %
glycerol, 1 mM phenylmethanesulfonyl fluoride, 1 mM
dithiothreitol). Telomerase IP with the sheep polyclonal
anti-TERT antibody, which was a gift from S. Cohen
(Children’s Medical Research Institute and University
of Sydney, Sydney, Australia) and telomerase activity
assay were performed as described in [6, 15].
Western blot and SNAP-tag fluorescence labeling
The protein samples were electrophoresed on a 4–12 %
Bis-Tris gel (Life Technologies), followed by standard
western blotting protocols. Primary antibodies used
were as follows: anti-TERT antibody (Abcam, ab32020,
1:1000), anti-GAPDH antibody (Santa Cruz, sc-137179,
1:1000), anti-FLAG horseradish peroxidase-conjugated
antibody (Sigma-Aldrich, A8592, 1:1000). Secondary
antibodies used were as follows: peroxidase-AffiniPure
donkey anti-rabbit IgG (H + L) (Jackson, 711-035-152,
1:5000), peroxidase-AffiniPure donkey anti-mouse IgG
(H + L) (Jackson, 715-035-150, 1:5000). SuperSignal®
West Pico Chemiluminescent Substrate (Thermo Scien-
tific) was used to generate signals on western blots. The
signals were detected with a FluorChem HD2 imaging
system (Alpha Innotech) and quantified with Image-
Quant TL v2005 software. To detect the SNAP-tag,
10 μM SNAP Surface® 594 (New England Biolabs,
S9112S) was added to the input samples at the begin-
ning of the IP. The fluorescence signals were detected
with a Typhoon Trio PhosphorImager (GE Healthcare)
and quantified using ImageQuant TL v2005 software.
Telomeric restriction fragment length analysis
For each sample, 1.5 μg genomic DNA was digested with
Hinf1 and Rsa1 at 37 °C for over 4 h and then electro-
phoresed on a 0.8 % agarose-1× TBE gel at 70 V for a
total of 1100 V-h together with a 5′ end 32P-labeled λ
DNA-HindIII digest ladder. Next, the gel was shaken in
the following solutions: 0.25 M HCl for 15 min, 0.5 M
NaOH–1.5 M NaCl for two rounds of 15 min and 0.5 M
Tris–1.5 M NaCl pH 7.5 for 30 min. Then the DNA was
transferred from the gel to the Hybond™-N+ membrane
(GE Healthcare) by capillary blotting with 20× SSC
buffer (3 M NaCl, 300 mM sodium citrate, pH 7.0), and
cross-linked to the membrane under UV 254 nm at
1200 × 100 μJ/cm2. The membrane was pre-hybridized
in Rapid-hyb buffer (GE Healthcare) at 35 °C for 30 min,
then hybridized in Rapid-hyb buffer with 5′ end 32P-
labeled (TTAGGG)3 probe at 35 °C for 1 h. After that,
the membrane was washed three times with 0.1× SSC,
0.1 % SDS at 50 °C for 20 min each time. The signals on
the membrane were detected with the Typhoon Trio
PhosphorImager and quantified with ImageQuant TL
v2005 software.
Cell growth rate analysis
Parental SCaBER cells and the three modified clones
were grown in T75 flasks. At each passage, the total cell
number in each flask was counted, and 0.1 million cells
were seeded in fresh growth medium. The cells were not
confluent during the culturing.
IF and live cell SNAP-labeling
The SNAP-tag was labeled using 1–2 μM SNAP-Cell®
647-SiR (New England Biolabs, S9102S) for 2–3 h in
DMEM containing 10 % FBS, 2 mM GlutaMAXTM-I, 100
units/ml penicillin and 100 μg/ml streptomycin at 37 °C
with 5 % CO2. Following SNAP-labeling, cells were
washed with PBS and pre-extracted with Triton X Buffer
(20 mM HEPES pH 7.9, 50 mM NaCl, 3 mM MgCl2,
300 mM sucrose, 0.5 % Triton X-100), for 1 min on ice,
rinsed with PBS and fixed with formaldehyde (4 % formal-
dehyde, 2 % sucrose in PBS) for 10 min at room
temperature. Cells were then re-permeabilized using
Triton X Buffer for 10 min at room temperature, and
incubated in blocking buffer (3 % BSA in PBS) for
30 min. After blocking, cells were incubated with primary
antibodies for TRF2 (Imgenex, IMG-124A, 1:500) and coi-
lin (Santa Cruz, sc-32860, 1:100) in blocking buffer for
1 h. Next, cells were washed with PBS and incubated with
secondary antibodies (Life Technologies, A-31556, and
Abcam, ab150117, 1:500) in blocking buffer for 1 h. After
a final wash, cells were mounted using ProLong® Diamond
Antifade Mountant (Life Technologies, P36970).
Cell cycle synchronization and flow cytometry analysis
For S-phase synchronization, cells were arrested in
growth medium containing 2 mM thymidine for 16 h.
To release the cells, they were washed three times with
PBS and cultured in regular growth medium for 3 h. For
the double thymidine block, cells were released for 9 h,
followed by a second thymidine arrest prior to release
into S phase as described above. To enrich for cells in
the G1 phase of the cell cycle, cells were arrested in mi-
tosis using growth medium supplemented with 100 ng/
ml nocodazole for 14–16 h. To release the cells into G1,
the mitotic cell population was washed three times with
PBS and cultured in regular growth medium. To deter-
mine the cell cycle distribution of the cell populations,
cells were fixed in 70 % ethanol and subsequently stained
with propidium iodide solution (0.2 mg/ml RNase A,
0.1 % Triton X-100, 20 μg/ml propidium iodide in PBS).
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Stained cells were analyzed using the FACScan sorter
(Becton-Dickinson).
Microscopy
All images were acquired on a Deltavision Core deconvolu-
tion microscope (Applied Precision) using a 60× 1.42NA
PlanApo N (Olympus) or 100× UPLanSApo 1.4NA (Olym-
pus) objective and a sCMOS camera. Twenty Z-sections
with 0.2 μm spacing were acquired for each image with
identical exposure conditions within each experiment. For
presentation in figures, representative images were decon-
volved (where indicated), followed by generation of max-
imum intensity projections of 5–10 Z-sections, which were
scaled identically for all experimental conditions.
Additional files
Additional file 1: Supplemental Figures S1–S6 and Tables S1–S3.
(PDF 12143 kb)
Additional file 2: A figure showing the TERT copy number analysis
for various cell lines generated in this study. (PDF 226 kb)
Additional file 3: Data file 3, is a detailed description of data files
4-15. Data files 4-15, which are maximum intensity projections of images
for all cell biological experiments, including images of an experiment
using a FLAG antibody to detect FLAG-SNAP-TERT in HeLa cells. (ZIP
43134 kb)
Additional file 4: Data files 16-19, which are sequences of all the
DT plasmids, as indicated by their names. Plasmids will be deposited
to Addgene. For the single base-pair modification step 1/2 DT (Data files
4 and 5 in Additional file 3), the −124 and −146 positions were modified
with the C > T mutations based on the detailed situation. (ZIP 13 kb)
Abbreviations
bp: base pair; BSA: bovine serum albumin; DMEM: Dulbecco’s modified Eagle
medium; DT: donor template; eGFP: enhanced green fluorescent protein;
FACS: fluorescence-activated cell sorting; FBS: fetal bovine serum;
HR: homologous recombination; IF: immunofluorescence; indel: small
insertions or deletion; IP: immunopurification; NHEJ: non-homologous end
joining; PBS: phosphate buffered saline; RT-qPCR: reverse transcription-
quantitative polymerase chain reaction; sgRNA: single guide RNA;
TERT: telomerase reverse transcriptase; TR: telomerase RNA; WT: wild type.
Competing interests
All authors declare that they have no competing interests.
Authors’ contributions
LX, JCS and TRC designed the experiments and drafted the manuscript. LX
designed and validated the CRISPR-Cas9 genome editing protocols,
generated the modified HEK 293, HEK 293T and SCaBER clones, examined
the telomere lengths of the HEK 293 clones, and performed all the analyses
on the HEK 293T and SCaBER clones. JCS participated in designing and
constructing the DT plasmids for FLAG-SNAP labeling, generated the modified
HeLa clones, and performed the subcellular localization analyses. AJZ analyzed
the expression and activity of FLAG-SNAP-TERT in the modified HEK 293 and
HeLa clones. DRA participated in constructing the DT plasmids for FLAG-SNAP-
labeling and clone screening. All authors read and approved the final
manuscript.
Authors’ information
T.R.C. is on the Board of Directors of Merck, Inc.
Acknowledgement
We thank the following colleagues at the University of Colorado Boulder: S.
Lin, S. Langer, S. Borah, N. Powell, K. Barthel and E. Davis for suggestions and
technical support; Y. Han for cell sorting; T. Nahreini for managing the Cell
Culture Facility. We thank Scott Cohen (Children’s Medical Research Institute
and University of Sydney, Sydney, Australia) for characterizing and providing
the anti-TERT antibody for IP. T.R.C. is an investigator of the Howard Hughes
Medical Institute. J.C.S. is a Merck fellow of the Damon Runyon Cancer Research
Foundation (DRG-2169-13). D.R.A. was supported by the Undergraduate
Research Opportunities Program at University of Colorado Boulder. This work
was supported in part by the National Institutes of Health (R01 GM099705 to
T.R.C., T32 GM08759 to L.X.).
Author details
1Howard Hughes Medical Institute, University of Colorado BioFrontiers
Institute, Boulder, CO, USA. 2Department of Molecular, Cellular &
Developmental Biology, University of Colorado, Boulder, CO, USA.
3Department of Chemistry & Biochemistry, University of Colorado, Boulder,
CO, USA.
Received: 17 July 2015 Accepted: 25 September 2015
References
1. Meyerson M. Role of telomerase in normal and cancer cells. J Clin Oncol.
2000;18:2626–34.
2. Lingner J, Hughes TR, Shevchenko A, Mann M, Lundblad V, Cech TR.
Reverse transcriptase motifs in the catalytic subunit of telomerase. Science.
1997;276:561–7.
3. Kilian A, Bowtell DD, Abud HE, Hime GR, Venter DJ, Keese PK, et al. Isolation
of a candidate human telomerase catalytic subunit gene, which reveals
complex splicing patterns in different cell types. Hum Mol Genet.
1997;6:2011–9.
4. Gunes C, Lichtsteiner S, Vasserot AP, Englert C. Expression of the hTERT
gene is regulated at the level of transcriptional initiation and repressed by
Mad1. Cancer Res. 2000;60:2116–21.
5. Shay JW, Bacchetti S. A survey of telomerase activity in human cancer. Eur J
Cancer. 1997;33:787–91.
6. Xi L, Cech TR. Inventory of telomerase components in human cells reveals
multiple subpopulations of hTR and hTERT. Nucleic Acids Res. 2014;42:8565–77.
7. Wu YL, Dudognon C, Nguyen E, Hillion J, Pendino F, Tarkanyi I, et al.
Immunodetection of human telomerase reverse-transcriptase (hTERT)
re-appraised: nucleolin and telomerase cross paths. J Cell Sci.
2006;119:2797–806.
8. Huang FW, Hodis E, Xu MJ, Kryukov GV, Chin L, Garraway LA. Highly
recurrent TERT promoter mutations in human melanoma. Science.
2013;339:957–9.
9. Horn S, Figl A, Rachakonda PS, Fischer C, Sucker A, Gast A, et al. TERT
promoter mutations in familial and sporadic melanoma. Science.
2013;339:959–61.
10. Borah S, Xi L, Zaug AJ, Powell NM, Dancik GM, Cohen SB, et al. Cancer. TERT
promoter mutations and telomerase reactivation in urothelial cancer.
Science. 2015;347:1006–10.
11. Scherer S, Davis RW. Replacement of chromosome segments with altered
DNA sequences constructed in vitro. Proc Natl Acad Sci U S A.
1979;76:4951–5.
12. Banik SS, Guo C, Smith AC, Margolis SS, Richardson DA, Tirado CA, et al.
C-terminal regions of the human telomerase catalytic subunit essential for
in vivo enzyme activity. Mol Cell Biol. 2002;22:6234–46.
13. Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, et al. Multiplex genome
engineering using CRISPR/Cas systems. Science. 2013;339:819–23.
14. Le Y, Miller JL, Sauer B. GFPcre fusion vectors with enhanced expression.
Anal Biochem. 1999;270:334–6.
15. Cohen SB, Graham ME, Lovrecz GO, Bache N, Robinson PJ, Reddel RR.
Protein composition of catalytically active human telomerase from immortal
cells. Science. 2007;315:1850–3.
16. Cohen SB, Reddel RR. A sensitive direct human telomerase activity assay.
Nat Methods. 2008;5:355–60.
17. Yang Y, Chen Y, Zhang C, Huang H, Weissman SM. Nucleolar localization of
hTERT protein is associated with telomerase function. Exp Cell Res.
2002;277:201–9.
18. Wong JM, Kusdra L, Collins K. Subnuclear shuttling of human telomerase
induced by transformation and DNA damage. Nat Cell Biol. 2002;4:731–6.
Xi et al. Genome Biology  (2015) 16:231 Page 16 of 17
19. Zhong FL, Batista LF, Freund A, Pech MF, Venteicher AS, Artandi SE. TPP1
OB-fold domain controls telomere maintenance by recruiting telomerase to
chromosome ends. Cell. 2012;150:481–94.
20. Schmidt JC, Dalby AB, Cech TR. Identification of human TERT elements
necessary for telomerase recruitment to telomeres. Elife. 2014;3. doi:
10.7554/eLife.03563.
21. Tomlinson RL, Ziegler TD, Supakorndej T, Terns RM, Terns MP. Cell
cycle-regulated trafficking of human telomerase to telomeres. Mol Biol
Cell. 2006;17:955–65.
22. Abreu E, Aritonovska E, Reichenbach P, Cristofari G, Culp B, Terns RM, et al.
TIN2-tethered TPP1 recruits human telomerase to telomeres in vivo. Mol
Cell Biol. 2010;30:2971–82.
23. Lukinavicius G, Umezawa K, Olivier N, Honigmann A, Yang G, Plass T, et al. A
near-infrared fluorophore for live-cell super-resolution microscopy of cellular
proteins. Nat Chem. 2013;5:132–9.
24. Jady BE, Richard P, Bertrand E, Kiss T. Cell cycle-dependent recruitment of
telomerase RNA and Cajal bodies to human telomeres. Mol Biol Cell.
2006;17:944–54.
25. Wu X, Scott DA, Kriz AJ, Chiu AC, Hsu PD, Dadon DB, et al. Genome-wide
binding of the CRISPR endonuclease Cas9 in mammalian cells. Nat
Biotechnol. 2014;32:670–6.
26. Yu Z, Ren M, Wang Z, Zhang B, Rong YS, Jiao R, et al. Highly efficient
genome modifications mediated by CRISPR/Cas9 in Drosophila. Genetics.
2013;195:289–91.
27. Ran FA, Hsu PD, Lin CY, Gootenberg JS, Konermann S, Trevino AE, et al.
Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing
specificity. Cell. 2013;154:1380–9.
28. Maruyama T, Dougan SK, Truttmann MC, Bilate AM, Ingram JR, Ploegh HL.
Increasing the efficiency of precise genome editing with CRISPR-Cas9 by
inhibition of nonhomologous end joining. Nat Biotechnol. 2015;33:538–42.
29. Chu VT, Weber T, Wefers B, Wurst W, Sander S, Rajewsky K, et al. Increasing
the efficiency of homology-directed repair for CRISPR-Cas9-induced precise
gene editing in mammalian cells. Nat Biotechnol. 2015;33:543–8.
30. Lin S, Staahl BT, Alla RK, Doudna JA. Enhanced homology-directed human
genome engineering by controlled timing of CRISPR/Cas9 delivery. Elife.
2014;3, e04766.
31. Zhao Y, Sfeir AJ, Zou Y, Buseman CM, Chow TT, Shay JW, et al. Telomere
extension occurs at most chromosome ends and is uncoupled from fill-in in
human cancer cells. Cell. 2009;138:463–75.
32. Teixeira MT, Arneric M, Sperisen P, Lingner J. Telomere length homeostasis
is achieved via a switch between telomerase- extendible and
-nonextendible states. Cell. 2004;117:323–35.
33. Gallardo F, Laterreur N, Cusanelli E, Ouenzar F, Querido E, Wellinger RJ, et al.
Live cell imaging of telomerase RNA dynamics reveals cell cycle-dependent
clustering of telomerase at elongating telomeres. Mol Cell. 2011;44:819–27.
34. Arnoult N, Schluth-Bolard C, Letessier A, Drascovic I, Bouarich-Bourimi R,
Campisi J, et al. Replication timing of human telomeres is chromosome
arm-specific, influenced by subtelomeric structures and connected to
nuclear localization. PLoS Genet. 2010;6, e1000920.
35. Fakhoury J, Marie-Egyptienne DT, Londono-Vallejo JA, Autexier C. Telomeric
function of mammalian telomerases at short telomeres. J Cell Sci.
2010;123:1693–704.
36. Britt-Compton B, Capper R, Rowson J, Baird DM. Short telomeres are
preferentially elongated by telomerase in human cells. FEBS Lett.
2009;583:3076–80.
37. Killela PJ, Reitman ZJ, Jiao Y, Bettegowda C, Agrawal N, Diaz Jr LA, et al.
TERT promoter mutations occur frequently in gliomas and a subset of
tumors derived from cells with low rates of self-renewal. Proc Natl Acad Sci
U S A. 2013;110:6021–6.
38. Weinhold N, Jacobsen A, Schultz N, Sander C, Lee W. Genome-wide analysis
of noncoding regulatory mutations in cancer. Nat Genet. 2014;46:1160–5.
39. Vinagre J, Almeida A, Populo H, Batista R, Lyra J, Pinto V, et al. Frequency of
TERT promoter mutations in human cancers. Nat Commun. 2013;4:2185.
40. Bell RJ, Rube HT, Kreig A, Mancini A, Fouse SD, Nagarajan RP, et al. Cancer.
The transcription factor GABP selectively binds and activates the mutant
TERT promoter in cancer. Science. 2015;348:1036–9.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Xi et al. Genome Biology  (2015) 16:231 Page 17 of 17
